Trius Therapeutics, Inc.
Part of Cubist Pharmaceuticals, Inc.
- UEI
- MCPHH5DJ3GR6
- CAGE
- 47YA5
- Primary NAICS
- 541711 Research and Development in Biotechnology
- SAM.gov registration
- Deleted
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
GW3PT4JEHQD5
-
Parent
GW3PT4JEHQD5
- SAM.gov registration date
- Website
- cubist.com
- Founded
- 1992
- Employees
- 251-1K
- Estimated annual revenue
- $500M-$1B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Identification of target-specific antimicrobials | National Institutes of Health | $2,000 | |
| Novel bacterial cell wall biosynthesis inhibitors for biodefense therapeutics | National Institutes of Health | $619,482 |
Quick answers
Is Trius Therapeutics, Inc. registered in SAM.gov?
Trius Therapeutics, Inc.'s SAM.gov registration was deleted on June 27, 2017.
What is Trius Therapeutics, Inc.'s most recent federal award?
Trius Therapeutics, Inc.'s most recent federal contract award is "development of therapeutic medical countermeasures for biodefense and emerging infectious diseases" 09/16/13… (HHSN272201300018C), from NIAID DEA OA Acquisitions (NIH), on September 12, 2013.
On GovTribe
See Trius Therapeutics, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors